2019 西班牙指南:靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用

2019-10-16 国外血液科相关专家小组 Br J Haematol. 2019 Oct 16.

随着下一代测序技术(NGS)的发展,医学测序的前景发生了迅速的改变,这些检测技术有助于检测骨髓增生异常综合征(MDS)和慢性粒单核细胞白血病(CMML)的分子特征。本文主要针对靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用提供指导,对于规范NGS数据的分析、临床解释和报告具有重要意义。

中文标题:

2019 西班牙指南:靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用

英文标题:

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

发布日期:

2019-10-16

简要介绍:

随着下一代测序技术(NGS)的发展,医学测序的前景发生了迅速的改变,这些检测技术有助于检测骨髓增生异常综合征(MDS)和慢性粒单核细胞白血病(CMML)的分子特征。本文主要针对靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用提供指导,对于规范NGS数据的分析、临床解释和报告具有重要意义。

 

拓展指南:白血病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 西班牙指南:靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用)] GetToolGuiderByIdResponse(projectId=1, id=5f0f51c00182810d, title=2019 西班牙指南:靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用, enTitle=Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia., guiderFrom=Br J Haematol. 2019 Oct 16., authorId=null, author=, summary=随着下一代测序技术(NGS)的发展,医学测序的前景发生了迅速的改变,这些检测技术有助于检测骨髓增生异常综合征(MDS)和慢性粒单核细胞白血病(CMML)的分子特征。本文主要针对靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用提供指导,对于规范NGS数据的分析、临床解释和报告具有重要意义。 , cover=, journalId=null, articlesId=null, associationId=971, associationName=国外血液科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Wed Oct 16 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>随着下一代测序技术(NGS)的发展,医学测序的前景发生了迅速的改变,这些检测技术有助于检测骨髓增生异常综合征(MDS)和慢性粒单核细胞白血病(CMML)的分子特征。本文主要针对靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用提供指导,对于规范NGS数据的分析、临床解释和报告具有重要意义。 </P> <P> </P>拓展指南:<strong>与<font color=red>白血病</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=14ac31c00180e319" title="NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2020.V2)" target=_blank>NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2020.V2)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=097811c001e89508" title="NCCN临床实践指南:急性髓性白血病(2020.V2)" target=_blank>NCCN临床实践指南:急性髓性白血病(2020.V2)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=8ed681c001e881e6" title="NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2020.V1)" target=_blank>NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2020.V1)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=2e16a1c001e87a01" title="NCCN临床实践指南:毛细胞白血病(2020.V1)" target=_blank>NCCN临床实践指南:毛细胞白血病(2020.V1)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=def5c1c001e87364" title="NCCN临床实践指南:慢性髓性白血病(2020.V1)" target=_blank>NCCN临床实践指南:慢性髓性白血病(2020.V1)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%99%BD%E8%A1%80%E7%97%85" target=_blank>有关白血病更多指南</a></ul>, tagList=[TagDto(tagId=96857, tagName=靶向深度测序), TagDto(tagId=2580, tagName=骨髓增生异常综合征), TagDto(tagId=34641, tagName=慢性粒单核细胞白血病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6048, appHits=130, showAppHits=8, pcHits=3905, showPcHits=3924, likes=42, shares=5, comments=4, approvalStatus=1, publishedTime=Mon Nov 18 01:09:24 CST 2019, publishedTimeString=2019-10-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 18 01:09:24 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:20:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 西班牙指南:靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用)])
2019 西班牙指南:靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=966298, encodeId=cff196629883, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e5495194, createdName=小李..., createdTime=Mon May 17 16:07:46 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926372, encodeId=6a929263e271, content=最新指南更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/44f6e6a567ca4840aba9e6bc5b3ed66f/0bcb7c90da454373a318cdcd1dd9463e.jpg, createdBy=db731387467, createdName=hongyantong, createdTime=Mon Feb 22 15:27:58 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905957, encodeId=d9b990595e46, content=积分不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cccd4809864, createdName=954561236, createdTime=Tue Dec 08 11:33:41 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2021-05-17 小李...

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=966298, encodeId=cff196629883, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e5495194, createdName=小李..., createdTime=Mon May 17 16:07:46 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926372, encodeId=6a929263e271, content=最新指南更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/44f6e6a567ca4840aba9e6bc5b3ed66f/0bcb7c90da454373a318cdcd1dd9463e.jpg, createdBy=db731387467, createdName=hongyantong, createdTime=Mon Feb 22 15:27:58 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905957, encodeId=d9b990595e46, content=积分不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cccd4809864, createdName=954561236, createdTime=Tue Dec 08 11:33:41 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2021-02-22 hongyantong

    最新指南更新

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=966298, encodeId=cff196629883, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e5495194, createdName=小李..., createdTime=Mon May 17 16:07:46 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926372, encodeId=6a929263e271, content=最新指南更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/44f6e6a567ca4840aba9e6bc5b3ed66f/0bcb7c90da454373a318cdcd1dd9463e.jpg, createdBy=db731387467, createdName=hongyantong, createdTime=Mon Feb 22 15:27:58 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905957, encodeId=d9b990595e46, content=积分不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cccd4809864, createdName=954561236, createdTime=Tue Dec 08 11:33:41 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2020-12-08 954561236

    积分不足

    0